Management of heart failure in the elderly.

The management of chronic heart failure in elderly patients is often complicated by the presence of multiple comorbid conditions, polypharmacy, psychosocial and financial concerns, and difficulties with adherence to complex medication and dietary regimens. In addition, few patients over 80 years of age have been enrolled in clinical trials, so that the efficacy of current heart failure therapies remains uncertain in this age group. Taken together, these factors contribute to the persistently high hospitalization and mortality rates as well as the poor quality of life associated with chronic heart failure in the elderly. In this article, nonpharmacologic aspects of care and the pharmacotherapy of systolic heart failure in elderly patients are reviewed. Optimal management requires a systematic approach comprising 5 key elements: coordination of care across disciplines, patient and caregiver education, enhancement of self-management skills, effective followup, and the judicious use of medications. However, it must be recognized that even with "best practice" interventions, the prognosis for established heart failure remains poor. Future research must therefore be directed at developing more effective strategies for the prevention of heart failure in our aging population.
AuthorsMichael W Rich
JournalHeart failure reviews (Heart Fail Rev) Vol. 7 Issue 1 Pg. 89-97 (Jan 2002) ISSN: 1382-4147 [Print] United States
PMID11790925 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Hydralazine
  • Digoxin
  • Isosorbide Dinitrate
  • Adrenergic beta-Antagonists (therapeutic use)
  • Aged
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Digoxin (therapeutic use)
  • Diuretics (therapeutic use)
  • Heart Failure (therapy)
  • Humans
  • Hydralazine (therapeutic use)
  • Isosorbide Dinitrate (therapeutic use)
  • Patient Education as Topic
  • Self Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: